Abstract
The present invention relates to immune stimulating micelle compositions, and their use in treatment of diseases and disorders, such as cancer. In particular, the present invention relates to micelle compositions comprising a TLR7 agonist, such as 1V270.
Original language | English |
---|---|
IPC | A61P 35/ 00 A I |
Patent number | WO2021053163 |
Filing date | 18/09/2020 |
Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
Priority date | 03/04/2020 |
Priority number | EP20200167952 |
Publication status | Published - 25 Mar 2021 |